UNSPSC 51152029: Fazadinium bromide

This classification denotes a nicotinic antagonist with the molecular formula C28H24N6.2Br, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8WV5538LFK, chemically known as 1,1-azobis(3-methyl-2-phenylimidazo(1,2-a)pyridinium) dibromide but generally known as fazadinium bromide, which bears US NIH Compound Identifier 5489112. European Medicines Agency schedules Fazadinium bromide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07516MIG.

UNSPSC 51152029 Fazadinium bromide is a Commodity code with minimal recent state and local procurement activity aligned to its nominal scope. The two recent opportunities tagged under this code show a substantial mismatch: Seminole County, Florida's IFB60459723LAS solicits Naloxone and Safe Drug Deactivation Systems (neither of which is fazadinium bromide), and the Texas Health and Human Services Commission's RFI HHS0017013 addresses direct-to-manufacturer prescription fulfillment models for a pharmacy benefit program — a strategic sourcing initiative unrelated to the purchase of any specific pharmaceutical commodity. The code does not appear to reflect active state and local demand for fazadinium bromide as a standalone procurement item.

No recent state and local opportunities substantively soliciting fazadinium bromide under this code are present in the source material. The Seminole County opportunity (IFB, response due July 26, 2023) and the Texas HHS RFI (response due April 3, 2026) are cataloged under the code but do not align with its stated product definition. Business development professionals monitoring this code should verify whether state and local purchasing offices are actively using this code for fazadinium bromide procurement or whether the category remains dormant for state and local government contracting purposes.